Clinical Psychopharmacology: Beyond Conventional Wisdom

Clinical Psychopharmacology: Beyond Conventional Wisdom is organized by University of Miami Miller School of Medicine Division of Continuing Medical Education and will be held from Mar 10 - 14, 2025 at Grand Beach Hotel, Miami, Florida, United States of America.

Overview:
This seminar aims to enhance clinicians' expertise in psychopharmacology by thoroughly exploring key concepts and contemporary practices. Participants will engage with a variety of conceptual models, comparing symptom-oriented and disease-oriented treatment approaches. We will critically evaluate the diagnostic validity of major psychiatric conditions and investigate evidence-based medication strategies tailored to these disorders. The seminar places a strong emphasis on diagnostic accuracy and the application of research-driven clinical practices, prioritizing efficacy and safety as demonstrated in clinical trials over speculative biological mechanisms. In-depth analysis and treatment strategies will be provided for schizophrenia, bipolar disorder, depression, and anxiety disorders, with additional focus on mixed states, bipolar depression, and the nuanced role of psychopharmacology in optimizing treatment outcomes. The seminar will incorporate the latest research findings, including recent advancements in clinical psychopharmacology, to ensure participants are equipped with up-to-date knowledge and skills. Special attention will be given to the application of these strategies in diverse patient populations, including children, the elderly, and those with comorbid medical conditions, to promote holistic and effective patient care.

ACCME Objectives:

• Describe a historical background on the major themes to be covered during the course;
• Discuss the biological mechanisms of major psychotropic drug classes;
• Grasp the basic neuroanatomy relevant to clinical psychopharmacology;
• Recognize and apply key clinical trials of drug classes for various diagnoses;
• Examine the validity of DSM diagnoses and learn how to use non-DSM approaches to diagnosis and drug treatment;
• Discuss practices with antipsychotics, mood stabilizers, and antidepressants;
• Explain the risks and side effects of major drug classes;
• Employ medications with an understanding of pharmacokinetic interactions;
• Identify factors in medication use for those with comorbid medical conditions.

APA Objectives:

• Explain historical background on the major themes to be covered during the course;
• Appraise the biological mechanisms of major psychotropic drug classes;
• Grasp the basic neuroanatomy relevant to clinical psychopharmacology;
• Compare practices with antipsychotics, mood stabilizers, and antidepressants;
• Analyze factors in medication use for those with comorbid medical conditions.
• Recognize and apply key clinical trials of drug classes for various diagnoses;
• Examine the validity of DSM diagnoses and learn how to use non-DSM approaches to diagnosis and drug treatment;
• Explain the risks and side effects of major drug classes;
• Employ medications with an understanding of pharmacokinetic interactions;